182 related articles for article (PubMed ID: 24375193)
1. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
Zhu ML; Hua RX; Zheng L
Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
[TBL] [Abstract][Full Text] [Related]
2. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
[TBL] [Abstract][Full Text] [Related]
3. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
[TBL] [Abstract][Full Text] [Related]
4. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
[TBL] [Abstract][Full Text] [Related]
5. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
[TBL] [Abstract][Full Text] [Related]
6. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
8. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
Jin B; Dong Y; Zhang X; Wang H; Han B
PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
[TBL] [Abstract][Full Text] [Related]
9. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.
Liu C; Yin Q; Hu J; Li L; Zhang Y; Wang Y
Tumour Biol; 2013 Apr; 34(2):1205-13. PubMed ID: 23381646
[TBL] [Abstract][Full Text] [Related]
11. [Association of XPC gene polymorphisms with breast cancer risk].
Wu YY; Ma XY; Yao KY; Li QL; Chen K
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 May; 40(3):252-8. PubMed ID: 21671483
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
[TBL] [Abstract][Full Text] [Related]
13. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
[TBL] [Abstract][Full Text] [Related]
15. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
Zhang Y; Wang X; Zhang W; Gong S
Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
[TBL] [Abstract][Full Text] [Related]
16. XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer.
Zhu XL; Sun XC; Chen BA; Sun N; Cheng HY; Li F; Zhang HM; Feng JF; Qin SK; Cheng L; Lu ZH
Chin Med J (Engl); 2010 Dec; 123(23):3427-32. PubMed ID: 22166526
[TBL] [Abstract][Full Text] [Related]
17. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
[TBL] [Abstract][Full Text] [Related]
18. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
[TBL] [Abstract][Full Text] [Related]
19. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
Dou K; Xu Q; Han X
Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
[TBL] [Abstract][Full Text] [Related]
20. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]